Different biotransformation of morphine in isolated liver cells from guinea pig and rat. 1993

T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
National Institute of Forensic Toxicology, Oslo, Norway.

The biotransformation of morphine was characterized in freshly isolated parenchymal and non-parenchymal liver cells from rats and guinea pigs in suspension culture to establish an in vitro model for morphine metabolism. Liver cells were prepared by a collagenase perfusion technique, and separated by differential centrifugation. Morphine metabolism was investigated at different concentrations (1, 5, 100 and 200 microM). Samples were taken repeatedly during 2-4 hr of incubation, and subsequently analysed on a HPLC system employing both UV and electrochemical detection. In suspensions of hepatocytes from both animal species morphine-3-glucuronide (M3G) was the major metabolite of morphine, and was formed at comparable rates at all concentrations examined. Guinea pig hepatocytes in addition produced considerable quantities of morphine-6-glucuronide (M6G), whereas this metabolite was detected only intracellularly in minor quantities in rat hepatocytes. The ratio between the two morphine glucuronides (M3G/M6G) in suspensions of guinea pig hepatocytes was approximately 4:1. N-Demethylation of morphine was more pronounced per mg cell protein in rat hepatocytes compared to guinea pig cells. Metabolic activity towards morphine was not detected in non-parenchymal cells of the two species. The morphine glucuronidation pattern found in guinea pig hepatocytes resembles to a greater extent than that found in rat hepatocytes the pattern found in in vivo studies of humans. It was concluded that isolated guinea pig parenchymal cells appeared to be a promising in vitro system for studies of morphine glucuronidation, and to observe metabolism in general.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009022 Morphine Derivatives Analogs or derivatives of morphine. Morphines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
February 1979, Xenobiotica; the fate of foreign compounds in biological systems,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
May 1977, Molecular and cellular biochemistry,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
January 1993, Drug metabolism and disposition: the biological fate of chemicals,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
February 1978, Biochemical pharmacology,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
March 1985, The American journal of physiology,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
September 1980, European journal of pharmacology,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
November 1975, The Biochemical journal,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
January 1977, Drug metabolism and disposition: the biological fate of chemicals,
T A Aasmundstad, and A Ripel, and E Bodd, and A Bjørneboe, and J Mørland
May 2004, Nutrition (Burbank, Los Angeles County, Calif.),
Copied contents to your clipboard!